Dr John Hales' Research Group
Our research group is focused on accelerating pharmaceutical research, development and manufacturing through our TRIFLE data platform and our virus laser technology.
Our research group develops novel analytical technologies to help pharmaceutical companies develop new medicines faster. By compressing timelines and expanding analytical capabilities, we aim to transform how medicines are developed and manufactured.
We have forged partnerships with global pharmaceutical companies, biotechs, contract manufacturers, and suppliers. These partnerships are critical to our work – guiding development, validating the technologies, and helping us shape the future of the sector's digital-and-analytical infrastructure.
Links
- Virus laser patent WO/2013/093499
- TRIFLE patent WO/2021/116493
- Future Leaders Fellowship (UKRI, MR/T02156X/1)
- Smart biomanufacturing for genomic medicines (UKRI, EP/X025446/1)
- AAV Formulation Consortium (InnovateUK, 10101620)
- Advanced Bioscience of Viral Products
- Virus-laser research article in Nature Communications
- TRIFLE research article
- GEN article about our recent work
- John Hales' UCL Research profile
- John Hales’ LinkedIn profile
